Literature DB >> 21158891

Associations of endogenous testosterone and SHBG with glycated haemoglobin in middle-aged and older men.

Judith S Brand1, Nicholas J Wareham, Mitch Dowsett, Elizabeth Folkerd, Yvonne T van der Schouw, Robert N Luben, Kay-Tee Khaw.   

Abstract

OBJECTIVE: Low circulating levels of testosterone and sex-hormone-binding globulin (SHBG) are associated with increased cardiovascular risk in men. This association may be partially mediated through changes in glucose metabolism, but relatively few data are available on the relationship between sex hormones and markers of long-term glycaemia. We assessed the associations of endogenous testosterone and SHBG with glycated haemoglobin (HbA(1c) ) in men. DESIGN AND
SUBJECTS: Cross-sectional study of 1292 men from the Norfolk population of European Prospective Investigation into Cancer (EPIC-Norfolk). MEASUREMENTS: Glycated haemoglobin, total testosterone (TT) and SHBG levels were measured, and free testosterone (FT) levels were calculated. Multiple linear regression models were used to assess the associations of TT, SHBG and FT with HbA(1c).
RESULTS: Men with diabetes had lower testosterone and SHBG levels. In non-diabetic men, HbA(1c) levels were inversely associated with TT and calculated FT independently of age, body mass index, smoking, alcohol consumption and physical activity. The adjusted change in HbA(1c) was 0·055 (95% CI 0·025; 0·085) per standard deviation (SD) decrease in TT and 0·041 (95% CI 0·010; 0·073) per SD decrease in calculated FT, respectively. SHBG levels were inversely associated with HbA(1c) after multivariable adjustment (β = 0·038 per SD decrease (95% CI 0·004; 0·071)).
CONCLUSIONS: In middle-aged and older men, low endogenous testosterone and SHBG levels are associated with glycaemia, even below the threshold for diabetes. Further studies are needed to determine the effects of interventions that raise testosterone levels in men having increased HbA(1c) and subnormal testosterone levels.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21158891     DOI: 10.1111/j.1365-2265.2010.03951.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  17 in total

Review 1.  Sex hormone-binding globulin and type 2 diabetes mellitus.

Authors:  Trang N Le; John E Nestler; Jerome F Strauss; Edmond P Wickham
Journal:  Trends Endocrinol Metab       Date:  2011-11-01       Impact factor: 12.015

2.  Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program.

Authors:  K J Mather; C Kim; C A Christophi; V R Aroda; W C Knowler; S E Edelstein; J C Florez; F Labrie; S E Kahn; R B Goldberg; E Barrett-Connor
Journal:  J Clin Endocrinol Metab       Date:  2015-07-22       Impact factor: 5.958

Review 3.  Histomorphometric and oxidative evaluation of the offspring's testis from type 2 diabetic female rats treated with metformin and pentoxifylline.

Authors:  Jessica Santana de Oliveira; Alluanan Adelson do Nascimento Silva; Fernanda Carolina Ribeiro Dias; Elizabeth Lopes de Oliveira; Emanuel Felipe de Oliveira Filho; Pierre Castro Soares; Catarina Michelle de Oliveira Ferreira; Valdemiro Amaro da Silva Junior
Journal:  Int J Exp Pathol       Date:  2022-06-23       Impact factor: 2.793

4.  Persistent organic pollutants and biomarkers of diabetes risk in a cohort of Great Lakes sport caught fish consumers.

Authors:  Mary Turyk; Giamila Fantuzzi; Victoria Persky; Sally Freels; Anissa Lambertino; Maria Pini; Davina H Rhodes; Henry A Anderson
Journal:  Environ Res       Date:  2015-04-22       Impact factor: 6.498

5.  Testosterone and dihydrotestosterone and incident ischaemic stroke in men in the Cardiovascular Health Study.

Authors:  Molly M Shores; Alice M Arnold; Mary L Biggs; W T Longstreth; Nicholas L Smith; Jorge R Kizer; Anne R Cappola; Calvin H Hirsch; Brett T Marck; Alvin M Matsumoto
Journal:  Clin Endocrinol (Oxf)       Date:  2014-05-05       Impact factor: 3.478

6.  Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study.

Authors:  A M Traish; A Haider; G Doros; F Saad
Journal:  Int J Clin Pract       Date:  2013-10-15       Impact factor: 2.503

7.  Influence of testosterone replacement therapy on metabolic disorders in male patients with type 2 diabetes mellitus and androgen deficiency.

Authors:  Shota Janjgava; Tamar Zerekidze; Lasha Uchava; Elene Giorgadze; Ketevan Asatiani
Journal:  Eur J Med Res       Date:  2014-10-23       Impact factor: 2.175

8.  The effects of a formal exercise training programme on salivary hormone concentrations and body composition in previously sedentary aging men.

Authors:  Lawrence D Hayes; Fergal M Grace; Nick Sculthorpe; Peter Herbert; John Wt Ratcliffe; Liam P Kilduff; Julien S Baker
Journal:  Springerplus       Date:  2013-01-22

9.  Poor glycemic control of diabetes mellitus is associated with higher risk of prostate cancer detection in a biopsy population.

Authors:  Juhyun Park; Sung Yong Cho; Young Ju Lee; Seung Bae Lee; Hwancheol Son; Hyeon Jeong
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

10.  Testosterone deficiency associated with poor glycemic control in korean male diabetics.

Authors:  Joo-Sung Kim; Bong Sun Kim; Ja Young Jeon; Yong Jun Choi; Yoon-Sok Chung
Journal:  Endocrinol Metab (Seoul)       Date:  2014-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.